BIG
CLB icon

Brooklyn Investment Group’s Core Laboratories CLB Stock Holding History

Brooklyn Investment Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$194K Buy
11,547
+321
+3% +$5.74K 0.01% 1723
2025
Q4 		$183K Buy
+11,226
New +$167K 0.01% 1395
2025
Q3 		– Sell
-1,027
Closed -$11.8K – 1056
2025
Q2 		$11.8K Buy
1,027
+998
+3,441% +$11.8K ﹤0.01% 2088
2025
Q1 		$435 Buy
+29
New +$485 ﹤0.01% 2512

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brooklyn Investment Group's CLB Position: Q1 2026 in Review

Brooklyn Investment Group increased its Core Laboratories (CLB) stake by 2.9% in Q1 2026, buying an estimated $5.74K and bringing the position to 11,547 shares worth $194K. The position accounts for 0.01% of the portfolio, ranked #1723.

Brooklyn Investment Group first reported a position in CLB in Q1 2025 and has held it in 4 quarters since. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Brooklyn Investment Group held 11,547 shares of Core Laboratories worth $194K as of Q1 2026.
  • Brooklyn Investment Group bought 321 Core Laboratories shares in Q1 2026, an estimated $5.74K.
  • Core Laboratories made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1723 holding.
  • Brooklyn Investment Group first reported a position in Core Laboratories in Q1 2025 and has held it in 4 quarters since.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.